Loading...Arm weakness is encountered rarely on Symcat. We will add more content to this page if enough people like you show interest.
The most common causes of arm weakness are stroke, brachial neuritis, and spinal stenosis. Other possible causes, such as spondylosis, are more rare.
Within all the people who go to their doctor with arm weakness, 71% report having leg weakness, 55% report having arm pain, and 55% report having loss of sensation.
Patients with arm weakness often receive radiographic imaging procedure, hematologic tests, complete blood count, plain x-ray, electrocardiogram, x-ray computed tomography, electrolytes panel and glucose measurement .
The most commonly prescribed drugs for patients with arm weakness include oxcarbazepine (trileptal), riluzole, aspirin / dipyridamole, tolazamide, loxapine, diethylpropion (tenuate), rasagiline (azilect), selegiline, bismuth subsalicylate (pepto-bismol), pyridostigmine (mestinon), fluorescein ophthalmic, interferon beta-1a (avonex) and piroxicam .
| Oxcarbazepine (Trileptal) | $95 (28 days) | |
| Riluzole | $890 (28 days) | |
| Tolazamide | $31 (28 days) | |
| Loxapine | $56 (28 days) | |
| Diethylpropion (Tenuate) | ||
| Rasagiline (Azilect) | $294 (28 days) | |
| Selegiline | $120 (28 days) | |
| Bismuth Subsalicylate (Pepto-Bismol) | $6 (14 days) | |
| Pyridostigmine (Mestinon) | $63 (28 days) | |
| Fluorescein Ophthalmic | ||
| Interferon Beta-1A (Avonex) | $2711 (28 days) | |
| Piroxicam | $34 (28 days) |
Groups of people at highest risk for arm weakness include age 75+ years age 45-59 years.
| < 1 years | 0.2x | |
| 1-4 years | 0.4x | |
| 5-14 years | 0.3x | |
| 15-29 years | 0.4x | |
| 30-44 years | 1.0x | |
| 45-59 years | 1.6x | |
| 60-74 years | 1.4x | |
| 75+ years | 1.6x |
| Male | 1.2x | |
| Female | 0.9x |
| Black | 1.0x | |
| Hispanic | 1.0x | |
| White | 1.0x | |
| Other | 1.2x |
Loading...This tool is for educational purposes only. It is NOT intended for diagnostic purposes. Only a physician or licensed provider may diagnose and treat diseases. Read the Terms and Conditions and Privacy Policy before use.
